vs
Side-by-side financial comparison of Dexcom (DXCM) and Fabrinet (FN). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.1B, roughly 1.1× Fabrinet). Dexcom runs the higher net margin — 21.2% vs 9.9%, a 11.3% gap on every dollar of revenue. On growth, Fabrinet posted the faster year-over-year revenue change (35.9% vs 21.6%). Over the past eight quarters, Fabrinet's revenue compounded faster (24.4% CAGR vs 12.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
FabrinetFNEarnings & Financial Report
Below is a list of companies having stocks that are included in the S&P MidCap 400 stock market index. The index, maintained by S&P Dow Jones Indices, comprises the common stocks of 400 mid-cap, mostly American, companies. Although called the S&P 400, the index sometimes contains more than 400 stocks when it includes two or more share classes of stock from one of its component companies.
DXCM vs FN — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.1B |
| Net Profit | $267.3M | $112.6M |
| Gross Margin | 62.9% | 12.2% |
| Operating Margin | 25.6% | 10.1% |
| Net Margin | 21.2% | 9.9% |
| Revenue YoY | 21.6% | 35.9% |
| Net Profit YoY | 153.6% | 30.0% |
| EPS (diluted) | $0.67 | $3.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.1B | ||
| Q3 25 | $1.2B | $978.1M | ||
| Q2 25 | $1.2B | $909.7M | ||
| Q1 25 | $1.0B | $871.8M | ||
| Q4 24 | $1.1B | $833.6M | ||
| Q3 24 | $994.2M | $804.2M | ||
| Q2 24 | $1.0B | $753.3M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $112.6M | ||
| Q3 25 | $283.8M | $95.9M | ||
| Q2 25 | $179.8M | $87.2M | ||
| Q1 25 | $105.4M | $81.3M | ||
| Q4 24 | $151.7M | $86.6M | ||
| Q3 24 | $134.6M | $77.4M | ||
| Q2 24 | $143.5M | $81.1M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 12.2% | ||
| Q3 25 | 60.5% | 11.9% | ||
| Q2 25 | 59.5% | 12.2% | ||
| Q1 25 | 56.9% | 11.7% | ||
| Q4 24 | 58.9% | 12.1% | ||
| Q3 24 | 59.7% | 12.3% | ||
| Q2 24 | 62.4% | 12.3% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 10.1% | ||
| Q3 25 | 20.1% | 9.6% | ||
| Q2 25 | 18.4% | 9.8% | ||
| Q1 25 | 12.9% | 9.0% | ||
| Q4 24 | 17.0% | 9.5% | ||
| Q3 24 | 15.3% | 9.6% | ||
| Q2 24 | 15.7% | 9.7% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 9.9% | ||
| Q3 25 | 23.5% | 9.8% | ||
| Q2 25 | 15.5% | 9.6% | ||
| Q1 25 | 10.2% | 9.3% | ||
| Q4 24 | 13.6% | 10.4% | ||
| Q3 24 | 13.5% | 9.6% | ||
| Q2 24 | 14.3% | 10.8% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $3.11 | ||
| Q3 25 | $0.70 | $2.66 | ||
| Q2 25 | $0.45 | $2.41 | ||
| Q1 25 | $0.27 | $2.25 | ||
| Q4 24 | $0.37 | $2.38 | ||
| Q3 24 | $0.34 | $2.13 | ||
| Q2 24 | $0.35 | $2.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $960.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $2.2B |
| Total Assets | $6.3B | $3.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $960.8M | ||
| Q3 25 | $1.8B | $968.8M | ||
| Q2 25 | $1.2B | $934.2M | ||
| Q1 25 | $904.9M | $950.7M | ||
| Q4 24 | $606.1M | $934.6M | ||
| Q3 24 | $621.2M | $908.9M | ||
| Q2 24 | $939.2M | $858.6M |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $2.2B | ||
| Q3 25 | $2.7B | $2.1B | ||
| Q2 25 | $2.6B | $2.0B | ||
| Q1 25 | $2.3B | $1.9B | ||
| Q4 24 | $2.1B | $1.8B | ||
| Q3 24 | $2.0B | $1.8B | ||
| Q2 24 | $2.4B | $1.7B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $3.3B | ||
| Q3 25 | $7.5B | $3.0B | ||
| Q2 25 | $7.3B | $2.8B | ||
| Q1 25 | $6.8B | $2.6B | ||
| Q4 24 | $6.5B | $2.5B | ||
| Q3 24 | $6.4B | $2.4B | ||
| Q2 24 | $6.8B | $2.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $46.3M |
| Free Cash FlowOCF − Capex | — | $-5.3M |
| FCF MarginFCF / Revenue | — | -0.5% |
| Capex IntensityCapex / Revenue | — | 4.6% |
| Cash ConversionOCF / Net Profit | — | 0.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $102.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $46.3M | ||
| Q3 25 | $659.9M | $102.6M | ||
| Q2 25 | $303.0M | $55.1M | ||
| Q1 25 | $183.8M | $74.2M | ||
| Q4 24 | $301.4M | $115.9M | ||
| Q3 24 | $199.5M | $83.2M | ||
| Q2 24 | $279.4M | $83.1M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $-5.3M | ||
| Q3 25 | $579.4M | $57.3M | ||
| Q2 25 | $208.9M | $4.7M | ||
| Q1 25 | $96.8M | $45.7M | ||
| Q4 24 | $176.8M | $94.0M | ||
| Q3 24 | $88.3M | $62.9M | ||
| Q2 24 | $213.3M | $70.4M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | -0.5% | ||
| Q3 25 | 47.9% | 5.9% | ||
| Q2 25 | 18.1% | 0.5% | ||
| Q1 25 | 9.3% | 5.2% | ||
| Q4 24 | 15.9% | 11.3% | ||
| Q3 24 | 8.9% | 7.8% | ||
| Q2 24 | 21.2% | 9.3% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 4.6% | ||
| Q3 25 | 6.7% | 4.6% | ||
| Q2 25 | 8.1% | 5.5% | ||
| Q1 25 | 8.4% | 3.3% | ||
| Q4 24 | 11.2% | 2.6% | ||
| Q3 24 | 11.2% | 2.5% | ||
| Q2 24 | 6.6% | 1.7% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 0.41× | ||
| Q3 25 | 2.33× | 1.07× | ||
| Q2 25 | 1.69× | 0.63× | ||
| Q1 25 | 1.74× | 0.91× | ||
| Q4 24 | 1.99× | 1.34× | ||
| Q3 24 | 1.48× | 1.07× | ||
| Q2 24 | 1.95× | 1.02× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
FN
| Optical Communications | $832.6M | 73% |
| Non Optical Communications | $300.3M | 27% |
